Immunogen Inc

FDA Filings

This page includes the latest FDA filings for Immunogen Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

USA

NASDAQ

IMGN

DUNS 011991874

FDA Filings

Device Company	Device	Date
ELAHERE ImmunoGen, Inc., BSP Pharmaceuticals S.p.A.	Prescription Medication	2024-11-01
ELAHERE ImmunoGen, Inc., BSP Pharmaceuticals S.p.A.	Prescription Medication	2024-09-22
ELAHERE ImmunoGen, Inc., BSP Pharmaceuticals S.p.A.	Prescription Medication	2024-09-15
ELAHERE ImmunoGen, Inc., BSP Pharmaceuticals S.p.A.	Prescription Medication	2024-04-06
ELAHERE ImmunoGen, Inc., BSP Pharmaceuticals S.p.A.	Prescription Medication	2023-04-08
ELAHERE ImmunoGen, Inc., BSP Pharmaceuticals S.p.A.	Prescription Medication	2023-03-09
ELAHERE ImmunoGen, Inc., BSP Pharmaceuticals S.p.A.	Prescription Medication	2022-11-24
761310 BLA IMMUNOGEN INC		2022-11-17 12:55:16
NDC 72903-853 ImmunoGen, Inc.	ELAHERE	2022-11-14

Similar & Related FDA Registered Companies

• BSP Pharmaceuticals S.p.A.

Related Finance Registrations

NCAGE Code	61CM8	IMMUNOGEN, INC.
CAGE Code	61CM8	IMMUNOGEN, INC.
SEC	0000855654	ImmunoGen, Inc. of MASSACHUSETTS